Literature DB >> 4811478

Cefazolin vs cephalothin and cephaloridine. A comparison of their clinical pharmacology.

C Regamey, R C Gordon, W M Kirby.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4811478

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  8 in total

1.  Dosage adjustments of cefazolin according to the pharmacokinetics of this new cephalosporin.

Authors:  J Lavillaureix; J M Brogard; M Pinget; F Ledoux
Journal:  Infection       Date:  1975       Impact factor: 3.553

2.  Pharmacokinetic interpretation of blood levels and urinary excretion data for cefazolin and cephalothin after intravenous and intramuscular administration in humans.

Authors:  E S Rattie; L J Ravin
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

3.  Pharmacokinetics of parenteral sodium cephalexin in comparison with cephalothin and cefazolin.

Authors:  C Regamey; R D Libke; J T Clarke; W M Kirby
Journal:  Infection       Date:  1974       Impact factor: 3.553

4.  Influence of serum protein binding and mode of administration on penetration of five cephalosporins into subcutaneous tissue fluid in humans.

Authors:  B Hoffstedt; M Walder
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

5.  Concentrations of cefazolin in human skeletal muscle.

Authors:  E Sinagowitz; K Pelz; A Burgert; W Kaczkowski
Journal:  Infection       Date:  1976       Impact factor: 3.553

6.  Pharmacokinetics of prophylactic cefazolin in parturients undergoing cesarean delivery.

Authors:  Mohammed H Elkomy; Pervez Sultan; David R Drover; Ekaterina Epshtein; Jeffery L Galinkin; Brendan Carvalho
Journal:  Antimicrob Agents Chemother       Date:  2014-04-14       Impact factor: 5.191

7.  Penetration of cefazolin, cephaloridine, and cefamandole into interstitial fluid in rabbits.

Authors:  C Carbon; A Contrepois; N Brion; S Lamotte-Barrillon
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

8.  Clinical on-site monitoring of ß-lactam antibiotics for a personalized antibiotherapy.

Authors:  R Bruch; C Chatelle; A Kling; B Rebmann; S Wirth; S Schumann; W Weber; C Dincer; G Urban
Journal:  Sci Rep       Date:  2017-06-09       Impact factor: 4.379
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.